Abstract:Background Rheumatoid arthritis (RA) is one of chronic autoimmune diseases that harm the human health for a long time. The pathogenesis of RA is still unknown, which refers to several aspects of the immune system. Especially, the aberrant activation of the lymphocytes and the NFκB dependent nonspecific inflammatory response are the two main points of joint inflammatory damage in RA. CD40/CD40L is the key co-stimulated molecular in the recognition and activation of the T cells. IκBα can suppress the inflammatory response and injury of joint synovium by cytokine at the key point by inhibiting the NFκB signaling. Objectives In this study, we used CD40LIg-IRES2- IκBα co-expressing adenovirus vector to transfect the synovium tissue of arthritic rats to investigate the genes expression as well as the effect on the arthritic rats. In addition, we will compare the therapeutic effect of the co-expression gene adenovirus and the single gene adenovirus vector, to explore the potential gene therapy for RA. Methods Construction of pAdCD40LIg, pAdIκBα and pAdCD40LIg-IRES2-IκBα adenovirus vector had completed. Wistar rats were rendered arthritic by multi-subcutaneous injection of complete Freund’s adjuvant. Arthritic rats were divided into four groups: group A with distal joint cavity injection of sterile water as control (n=5); group B with injection of pAdCD40LIg vector (n=5); group C with pAdIκBα vector injection (n=5); and group D with injection of pAdCD40LIg-IRES2-IκBα vector (n=5). Therapy effects were measured by the method of arthritis index score of rats. The levels of TNF-α, IL-2, IL-6 in synovial fluid collected by joint puncture were measured by ELISA methods 21 days after treatment. Results The mean arthritis index score of rats in group D was significantly lower than those in other three groups (P<0.05). The index in group B and C were significantly lower than that in group A (P<0.05). The rats in group D had the lowest TNF-α, IL-2 and IL-6 levels in synovial fluid followed by group C, B and A (P<0.05). Conclusions The expression CD40LIg and IκBα can effectively inhibit inflammatory reaction of arthritic rats. Simultaneous expression CD40LIg and IκBα can improve the therapeutic effect by synergistic effect. References Munroe ME, Bishop GA. A costimulatory function for T cell CD40. J Immunol, 2007, 178(2):671-682. Makarov SS. NF-κB in rheumatoid arthritis:a pivtoal regulator of inflmmation, hyperplasia and tissue destruction. Arthritis Res, 2001, 3(4):200-206. Malfait AM, Williams RO, Malik AS, et al. Chronic relapsing homologous collagen-indueed arthritis in DBA/1 mice as a model for testing disease-modifying and remission-inducing therapies. Arthritis Rheum, 2001, 44(5):1215-1224 Disclosure of Interest None Declared

Bim-Bcl-2 homology 3 mimetic therapy is effective at suppressing inflammatory arthritis through the activation of myeloid cell apoptosis

Apremilast Ameliorates Experimental Arthritis Via Suppression of Th1 and Th17 Cells and Enhancement of CD4+Foxp3+ Regulatory T Cells Differentiation

The Bispecific Antibody Aimed at the Vicious Circle of IL-1β and IL-17A, is Beneficial for the Collagen-Induced Rheumatoid Arthritis of Mice Through NF-κB Signaling Pathway.

Therapeutic Efficacy of Three Bispecific Antibodies on Collagen-Induced Arthritis Mouse Model.

Polymorphonuclear Myeloid-Derived Suppressor Cells Play a Proinflammatory Role Via TNF-α+ B Cells Through BAFF/BTK/NF-κB Signalling Pathway in the Pathogenesis of Collagen-Induced Arthritis Mice

[Therapeutic Efficacy of Three Bispecific Antibodies on Rheumatoid Arthritis Mice Models].

Bim suppresses the development of SLE by limiting myeloid inflammatory responses

Irreversible inhibition of BTK kinase by a novel highly selective inhibitor CHMFL-BTK-11 suppresses inflammatory response in rheumatoid arthritis model

A Bispecific Antibody Against IL-1β and IL-17A is Beneficial for Experimental Rheumatoid Arthritis

Therapeutic Effects of a Novel BAFF Blocker on Arthritis

Cyclin-dependent kinase inhibitor p21, via its C-terminal domain, is essential for resolution of murine inflammatory arthritis

AIM/CD5L ameliorates autoimmune arthritis by promoting removal of inflammatory DAMPs at the lesions

Remission Of Collagen-Induced Arthritis Through Combination Therapy Of Microfracture And Transplantation Of Thermogel-Encapsulated Bone Marrow Mesenchymal Stem Cells

A novel tricyclic BTK inhibitor suppresses B cell responses and osteoclastic bone erosion in rheumatoid arthritis

Chimeric Anti-Il-17 Full-Length Monoclonal Antibody is A Novel Potential Candidate for the Treatment of Rheumatoid Arthritis

Multiple BH3 mimetics antagonize antiapoptotic MCL1 protein by inducing the endoplasmic reticulum stress response and up-regulating BH3-only protein NOXA

Efficacy and safety implications of molecular constructs of biological agents for rheumatoid arthritis

Transformable peptide blocks NF-κB/IκBα pathway through targeted coating IκBα against rheumatoid arthritis

AB0177 Simultaneous Blockade of the CD40/CD40L and NF-κB Pathways Improving Therapy Effect on Arthritic Rats

Therapeutic Effects of IL-1RA, M2 Cells, and Their Synergistic Impact on a Mouse Model of Rheumatoid Arthritis

CXCR3 antagonist NBI-74330 mitigates joint inflammation in Collagen-Induced arthritis model in DBA/1J mice